Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Renhe Pharma Plans $140 Million Fund Raise for M&A

publication date: Mar 2, 2011
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Renhe Pharmacy has plans for a 50 million share private placement, priced at 18.36 RMB per share, which will bring in 918 million RMB ($139.7 million). Renhe, which makes and distributes OTC drugs, will use the money to buy stakes in four companies. More details....

Stock Symbol: (SHE: 000650)

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...